NCT07613801

Brief Summary

Investigators will compare FASCIA ILIACA BLOCK VERSUS INTRAVENOUS NALBUPHINE AS ANALGESIC METHOD BEFORE POSITIONING FOR SPINAL ANESTHESIA IN PATIENTS UNDERGOING SURGERY FOR HIP FRACTURES

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for phase_4

Timeline
5mo left

Started May 2026

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress19%
May 2026Nov 2026

Study Start

First participant enrolled

May 12, 2026

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

May 14, 2026

Completed
15 days until next milestone

First Posted

Study publicly available on registry

May 29, 2026

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 12, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 12, 2026

Last Updated

May 29, 2026

Status Verified

May 1, 2026

Enrollment Period

6 months

First QC Date

May 14, 2026

Last Update Submit

May 21, 2026

Conditions

Hip Fracture Surgeries

Outcome Measures

Primary Outcomes (2)

  • Pain score(VAS score) after 15 minutes of either intervention before spinal anesthesia

    15 minutes

  • Quality of positioning for spinal anesthesia after 15 minutes of either intervention

    Scale of 0-3 for hip flexion while sitting after either intervention 0=not satisfactory (poor hip flexion) 1. satisfactory (slight hip flexion) 2. good (adequate hip flexion) 3. optimal (excellent hip flexion)

    15 minutes

Secondary Outcomes (3)

  • Assessment of heart rate

    15 minutes

  • Assessment of blood pressure

    15 minutes

  • Comfort of patient

    15 minutes

Study Arms (2)

Fascia ILIACA block

ACTIVE COMPARATOR

We will compare this with nalbuphine

Drug: Bupivacain

Nalbuphine

ACTIVE COMPARATOR

We will compare this with fascia ILIACA block

Drug: Nalbuphine

Interventions

BupivacainDRUG

We will compare fascia ILIACA block with nalbuphine

Fascia ILIACA block
NalbuphineDRUG

We will compare this with fascia ilaca block

Nalbuphine

Eligibility Criteria

Age30 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age above 30 years

You may not qualify if:

  • Age before 30

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Liaquat National Hospital

Karachi, Pakistan

Location

MeSH Terms

Interventions

BupivacaineNalbuphine

Intervention Hierarchy (Ancestors)

AnilidesAmidesOrganic ChemicalsAniline CompoundsAminesMorphinansOpiate AlkaloidsAlkaloidsHeterocyclic CompoundsHeterocyclic Compounds, Bridged-RingHeterocyclic Compounds, 4 or More RingsHeterocyclic Compounds, Fused-RingPhenanthrenesPolycyclic Aromatic HydrocarbonsPolycyclic Compounds

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident Fellowship

Study Record Dates

First Submitted

May 14, 2026

First Posted

May 29, 2026

Study Start

May 12, 2026

Primary Completion (Estimated)

November 12, 2026

Study Completion (Estimated)

November 12, 2026

Last Updated

May 29, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Locations

PA(1)